Imaging modalities for drug-related osteonecrosis of the jaw (2), Overview of the position paper on medication-related osteonecrosis of the jaw and the current status of the MRONJ in Japan
Summary: Since Marx reported on osteonecrosis of the jaw caused by the injectable bisphosphonates (BPs) pamidronate and zoledronate, there have been numerous reports not only in Western countries, but in Japan as well, of bisphosphonate-related osteonecrosis of the jaw (BRONJ) as a pathology similar...
Saved in:
Main Author: | Takahiko Shibahara (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2019-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of Teriparatide in Medication-Related Osteonecrosis of the Jaws (MRONJ)
by: Yong-Dae Kwon, et al.
Published: (2016) -
Imaging in Patients with Bisphosphonate-Associated Osteonecrosis of the Jaws (MRONJ)
by: Britt-Isabelle Berg, et al.
Published: (2016) -
Panoramic Radiography Features of Medication-Related Osteonecrosis of the Jaws (MRONJ)
by: Rossana Izzetti, et al.
Published: (2023) -
Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (4), CT and MR imaging findings of antiresorptive agent-related osteonecrosis of the jaws/medication-related osteonecrosis of the jaw (secondary publication)
by: Akira Baba, et al.
Published: (2019) -
Imaging modalities for drug-related osteonecrosis of the jaw (3), Positron emission tomography imaging for the diagnosis of medication-related osteonecrosis of the jaw
by: Yoshimasa Kitagawa, et al.
Published: (2019)